Full Paper
the mixture at 08C, which was warmed to room temperature over
12 h. The mixture was diluted with excess dichloromethane,
washed with water (5ꢂ), dried over anhydrous sodium sulfate, and
evaporated under reduced pressure to give a dark-brown liquid.
The crude product was purified by column chromatography with
petroleum ether/diethyl ether as the eluent to give 5 as a dark-
brown solid in 35% yield. 1H NMR (CDCl3): d=7.51 (d, J=8.4 Hz,
1H), 7.44 (t, J=6.8 Hz, 2H), 7.33 (d, J=8 Hz, 1H), 7.24–7.28 (q, J=
5.6 Hz, 1H), 5.87 (s, 1H), 3.61–3.67 (m, 2H), 3.41–3.45 ppm (m, 2H);
13C NMR (CDCl3): d=141.4, 141.3, 139.7, 137.6, 132.9, 129.1, 128.0,
125.2, 123.6, 122.8, 58.9, 41.0 ppm; 77Se NMR (CDCl3): d=453,
382 ppm.
to T3 at lower concentrations, thus indicating that intermolec-
ular interactions play an important role in deiodination. Single-
crystal X-ray studies of T3 indicated the presence of novel I···I
halogen bonds, which are absent in the crystal structure of
T3AM. These observations suggest that not only the halogen
bond between the iodine and selenium atoms, but also I···I in-
termolecular interactions, facilitate deiodination of thyroid hor-
mones.
Experimental Section
Synthesis of T4AM: N-tert-butoxycarbonyl-3,3’,5,5’-tetraiodothyr-
onamine (200 mg, 0.24 mmol) was stirred in 1:4 (v/v) mixture of tri-
fluoroacetic acid and dichloromethane for 1 h. The solvent was
evaporated under vacuum to yield a yellow–white sticky solid.
T4AM was purified from the crude reaction mixture by using a re-
verse-phase HPLC with a C18 column (Atlantis; 250ꢂ19 mm, I.D.=
10 mm) and methanol/water (70:30) as the mobile phase. T4AM-
containing fractions were lyophilised to yield a white solid in 90%
General procedure
Tyramine, iodine monochloride (ICl), triisopropylborate, tetrabutyl-
ammonium fluoride (TBAF), borontrifluoride diethyletherate
(BF3·Et2O), ethanedithiol, selenium powder, T4, rT3, T3, and acetoni-
trile were purchased from Sigma–Aldrich. n-Butyllithium (nBuLi)
was obtained from Acros Chemical Co. (Belgium). Dithiothreitol
(DTT) and anhydrous cupric acetate were obtained from Alfa Aesar.
Trifluoroacetic acid (TFA) and precoated silica-gel plates were pur-
chased from Merck. Liquid-state NMR spectra were recorded in
1
yield. H NMR ([D4]MeOH): d=7.89 (s, 2H), 7.10 (s, 2H), 3.22 (t, J=
7.6 Hz, 2H), 2.94 ppm (t, J=7.6 Hz, 2H); 13C NMR ([D4]MeOH): d=
153.3, 151.6, 150.7, 141.0, 138.6, 126.2, 91.1, 84.7, 40.4, 31.8 ppm;
MS (ESI): m/z calcd for C14H11NO2I4: 733.7 ([M+H]+); found 734.06.
CDCl3, [D4]MeOH, or [D6]DMSO as a solvent. H, 13C, and 77Se NMR
1
spectra were obtained using a Bruker 400 MHz NMR spectrometer
(400, 100.56, 76.29 MHz, respectively). Chemical-shift values are
cited with respect to SiMe4 as an internal (1H and 13C) and Me2Se
as an external (77Se) standard. Column chromatography was carried
out in glass columns or in an automated flash-chromatography
system (Biotage) by using preloaded silica cartridges. HPLC experi-
ments were performed on a Waters Alliance system (Milford, MA,
USA) consisting of a 2695 separation module and a 2996 photo-
diode-array detector. HPLC sample vials (1.7 mL) were used to
carry out the deiodinase assays, and a built-in auto-sampler was
used for sample injection. The HPLC system was controlled by EM-
POWER software (Waters corporation, Milford, MA, USA). Single-
crystal X-ray diffraction data were obtained from a Bruker Kappa
Apex II X-ray diffractometer with a CCD detector. Compounds 20
and 21 were synthesised by following a reported procedure.[7,9]
Synthesis of T3AM: This compound was synthesised by using N-
tert-butoxycarbonyl-3,3’,5-triiodothyronamine (200 mg, 0.28 mmol)
as described earlier for T4AM in 92% yield. 1H NMR ([D4]MeOH):
d=7.89 (s, 2H), 7.00 (d, J=2.8 Hz, 1H), 6.78 (d, J=8.8 Hz, 1H),
6.64–6.67 (dd, J=6.4 Hz, 1H), 3.23 (t, J=8 Hz, 2H), 2.95 (t, J=
7.2 Hz, 2H); 13C NMR ([D4]MeOH): d=153.9, 152.5, 149.9, 141.0,
138.2, 125.6, 116.8, 115.0, 91.4, 83.4, 40.5, 31.8; MS (ESI): m/z calcd
for C14H13NO2I3: 607.81 ([M+H]+); found: 607.77.
Synthesis of rT3AM: This compound was synthesised by using N-
tert-butoxycarbonyl-3,3’,5’-triiodothyronamine (200 mg, 0.28 mmol)
1
as described earlier for T4AM in 95% yield. H NMR [D4]MeOH): d=
7.85 (s, 1H), 7.31 (s, 3H), 6.91 (d, J=8.4 Hz, 1H), 4.64 (br, s, 2H),
3.19 (t, J=7.6 Hz, 2H), 2.9 ppm (t, J=7.6 Hz, 2H); 13C NMR
([D4]MeOH): d=156.0, 152.6, 151.3, 140.5, 135.0, 130.7, 129.0, 119.8,
88.8, 84.5, 40.7, 32.3 ppm; MS (ESI): m/z calcd for C14H13NO2I3:
607.81 ([M+H]+); found: 607.71.
Deiodination assays
Synthesis of 3,3’-T2AM: This compound was synthesised by using
N-tert-butoxycarbonyl-3,3’-diiodothyronamine (200 mg, 0.34 mmol)
as described earlier for T4AM in 93% yield. 1H NMR ([D4]MeOH):
d=7.81 (d, J=2 Hz, 1H), 7.22–7.24 (q, J=4 Hz, 2H), 6.84 (t, J=
2.8 Hz, 1H), 6.78 (d, J=8.4 Hz, 1H), 3.16 (t, J=8 Hz, 2H), 2.91 ppm
(t, J=7.6 Hz, 2H); 13C NMR ([D4]MeOH): d=157.0, 153.9, 149.9,
140.3, 133.9, 130.4, 129.4, 120.2, 118.5, 115.1, 88.0, 83.4, 40.8,
32.3 ppm; MS (ESI): m/z calcd for C14H14NO2I2: 481.91 ([M+H]+);
found: 481.85.
The deiodination reactions of thyroid hormones and iodothyron-
amines were carried out in a mixture of 20% (v/v) acetonitrile and
phosphate buffer (100 mm, pH 7.00) at 378C in the presence of
15 mm DTT. Acetonitrile was used to increase the solubility of iodo-
thyronamines in phosphate buffer at physiological pH values. The
selenol compounds (1.2 mm) were freshly prepared by reducing
the corresponding diselenide with sodium borohydride. To deter-
mine the initial rate of deiodination, the deiodination of thyroid
hormones or iodothyronamines (0.3 mm) was followed during the
initial period (ca. 10%) of the reaction. The deiodinated products
were analysed by using reverse-phase HPLC (Princeton C18
column; 150ꢂ5 mm, I.D.=5 mm) with gradient elution and aceto-
nitrile/ammonium acetate/acetic acid buffer (15 mm, pH 4) as the
mobile phase. The formation of deiodinated products was moni-
tored at l=275 nm, and the yields of their formation were calcu-
lated from the corresponding peak areas.
Single-crystal X-ray crystallography
Compound 5 was recrystallised from chloroform by using the
slow-evaporation method. Dark-brown crystals were filtered,
washed with petroleum ether, and dried under high vacuum. T3
was recrystallised with trifluoroacetic acid from a solution of dieth-
yl ether and ethyl acetate (1:1). The needle-shaped white crystals
obtained from the solution were dried under vacuum. T3AM was
also recrystallised as a trifluoroacetate salt by following a similar
procedure. The single-crystal X-ray diffraction data of 5, T3, and
T3AM were collected on a Bruker SMART APEX CCD diffractometer
by utilizing SMART/SAINT software.[22] Intensity data were collected
by using graphite-monochromatised MoKa radiation of wave-
Synthesis
Synthesis of 5: 1,2-Ethanedithiol (46 mg, 0.49 mmol) was added to
a solution of 21 (100 mg, 0.32 mmol) in dry dichloromethane
(20 mL). The resulting solution was cooled to 08C. Borontrifluoride
diethyl etherate (80 mL, 45–50% solution) was added dropwise to
Chem. Eur. J. 2014, 20, 1 – 10
7
ꢀ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
&
&
These are not the final page numbers! ÞÞ